Diagnostic Test Accuracy of Screening Tools for Post-Traumatic Stress Disorder Among Refugees and Asylum Seekers: A Systematic Review and Meta-Analysis
In: JMHEALTH-D-22-00053
5 Ergebnisse
Sortierung:
In: JMHEALTH-D-22-00053
SSRN
In: Cochrane evidence synthesis and methods, Band 2, Heft 11
ISSN: 2832-9023
AbstractBackgroundGiven the colonial connotations of the term "stakeholder", its continued use may be perceived as disrespectful to Indigenous Peoples. While several groups have introduced alternative terms, each has its own limitations. The objective of this article is to introduce "interest‐holders" as an alternative term to "stakeholders" and describe the discussions underpinning the adoption of the new term by the MuSE Consortium.MethodsThe MuSE Consortium is an international network of over 160 individuals with interest and expertise in different aspects relevant to engagement in research. Members of MuSE explored alternative terms and considered their respective merits and limitations. The deliberations considered the literature on the topic and the results of two consultations with the wider MuSE membership on the alternative terms.ResultsWe define "interest‐holders" as groups with legitimate interests in the health issue under consideration. The interests arise and draw their legitimacy from the fact that people from these groups are responsible for or affected by health‐related decisions that can be informed by research evidence.ConclusionAs groups other than the MuSE Consortium have started to adopt "interest‐holders," we hope its use will reduce confusion related to the multitude of terms used and convey the intended meaning without any negative connotations.
In: Cochrane evidence synthesis and methods, Band 1, Heft 3
ISSN: 2832-9023
AbstractIntroductionHealth equity is a moral and ethical imperative for clinicians, researchers, policymakers, and all who use health research. Both Cochrane and the Campbell Collaboration have focused on health equity for many years.MethodsThe new Equity Group will continue and expand this work by designing a program of projects aiming to (1) promote equity in the evidence base, (2) ensure equitable processes for stakeholder engagement, (3) produce high‐priority, equity‐focused evidence syntheses, (4) build capacity for equity design, analysis, and reporting, and (5) promote equity in implementation tools.ResultsWe will build on our current network of collaborators and create a group structure striving to recruit across the PROGRESS‐Plus characteristics.ConclusionWe invite readers to join our cause and contribute wherever they are able. Together, we can help Cochrane achieve its social responsibility of improving health equity at a planetary level.
In: JCEPI-D-22-00089
SSRN
In: Cochrane evidence synthesis and methods, Band 2, Heft 6
ISSN: 2832-9023